Abstract
In previous work we showed that macrophages must produce oxygen radicals in order to kill pathogenic organisms (1). Oxygen radical production by mouse peritoneal macrophages could be enhanced at least ten-fold if the macrophages were previously “activated”. (Throughout this paper we use the term “activated” to mean “primed to release optimal amounts of O −2 when stimulated”). Macrophages were activated either by infecting the animals with Mycobacterium bovis, strain BCG, or by injecting them with bacterial lipopolysaccharide (LPS) or muramyl dipeptide (MDP) (2, 3). Cultured macrophages could also be activated in vitro by addition of LPS or MDP to the cultures (4). Treatment with LPS or MDP enhanced the ability of cultured macrophages to kill bacteria and fungi in vitro (1, 3). Treatment of mice with MDP in vivo enabled them to resist an otherwise lethal challenge infection with Klebsiella pneumoniae or Candida albicans (3, 5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sasada, M., and R. B. Johnston, Jr. 1980. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J. Exp. Med. 152: 85.
Johnston, R. B., Jr., C. A. Godzik and Z. A. Cohn. 1978. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J. Exp. Med. 148: 115.
Cummings, N. P., M. J. Pabst and R. B. Johnston, Jr. 1980. Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. J. Exp. Med. 152: 1659.
Pabst, M. J. and R. B. Johnston, Jr. 1980. Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J. Exp. Med. 151: 101.
Chedid, L., M. Parant, F. Parant, F. Audibert, F. LeFrancier, J. Choay, and M. Sela. 1979. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly (DL-alanine)-poly(L-lysine) carrier. Proc. Natl. Acad. Sci. 76: 6557.
Pabst, M. J., H. B. Hedesgaard, and R. B. Johnston, Jr. 1982. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J. Immunol. 128: 123.
Hedegaard, H. B., and M. J. Pabst. 1982. Preservation of superoxide anion-generating capacity in cultured human monocytes by treatment with muramyl dipeptide or lipopolysaccharide, p. 205 208. Y. Yamamura et al (eds.), In Immunomodulation by Microbial Products and Related Synthetic Compounds. Excerpta Medica, Amsterdam.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pabst, M.J., Cummings, N.P., Hedegaard, H.B., Johnston, R.B. (1983). Human Macrophages May Normally be “Primed” for a Strong Oxygen Radical Response. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1410-4_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1412-8
Online ISBN: 978-1-4757-1410-4
eBook Packages: Springer Book Archive